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Summary
Introduction: Leptospirosis, an under-recognized public health problem, needs to be confirmed
through specific laboratory diagnosis.
Design: We describe herein a series of 4618 symptomatic patients for whom a microagglutination
test (MAT) serology was available, representing a unique picture of human leptospirosis in central
mainland Portugal and the Azores islands of Sa˜o Miguel and Terceira, over eighteen- and twelve-
year periods, respectively.
Results: The distribution of the 1024 (22%) cases identified was an average 57 cases per year, with
higher frequency in males (67%). These represent the majority of leptospirosis notifications in
Portugal, with a higher annual incidence rate in the islands, compared to the central mainland
(11.1 and 1.7/100 000 population, respectively). Middle-aged adults (25—54 years) were most
frequently infected (45%). Cases occurred mainly in December and January. Serovars from nine
presumptive serogroups caused infection, with a predominance of Icterohaemorrhagiae,
Pomona, and Ballum, accounting for 66% of cases.
Conclusions: Seropositivity was associated with both anicteric and icteric leptospirosis. Several
risk factors and a higher transmission risk in certain areas were emphasized. Leptospirosis was
confirmed as a steadily increasing public health problem; good surveillance, communication, and
laboratory support are thus necessary to reduce the impact of leptospirosis in areas at risk.
# 2006 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights
reserved.* Corresponding author. Tel.: +351 213652600;
fax: +351 213632105.
E-mail address: mcp@ihmt.unl.pt (M. Collares-Pereira).
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Leptospirosis is a globally important zoonotic disease that
affects humans on all continents in tropical and temperate
climates, now being identified as one of the emerging infec-
tious diseases.1—3 Bacteria from the family Leptospiraceae
are the causative agents.Published by Elsevier Ltd. All rights reserved.
Human leptospirosis in Portugal 379The natural reservoirs for leptospires are wild animals,
particularly rodents, and domestic animals, commonly
bovines and pigs, which, after infection, can become
chronic renal carriers. Human infection is accidental,
usually occurring after direct or indirect contact with urine
from leptospiruric animals. Indirect exposure through
water, soil or vegetation contaminated with urine accounts
for most sporadic cases in occupational groups such as
farmers, sewer workers and military personnel, while direct
exposure occurs in veterinarians and farmers working with
livestock.4
Previously regarded as an occupational illness, its epi-
demiological pattern is changing and now there are increas-
ing reports of leptospirosis contracted during accidental
events in waters polluted with leptospires and during
recreational activities.5,6 In addition, a number of retro-
spective epidemiological studies have recently been pub-
lished in countries of temperate zones7,8 and tropical
areas,9,10 aiming to summarize the regional features and
trends in human leptospirosis cases.
In Portugal, the first isolation of the agent of Weil’s
disease was obtained in 1931.11 However, regular research
on human Leptospira infection (International classification
of diseases (ICD), 10th revision: 100—100.9) started in the
1980s,12 becoming a notifiable disease in 1987 for all lep-
tospires; Icterohaemorrhagiae cases have been notifiable
since 1950.
So far, the number of officially reported cases has been
low in mainland Portugal,13,14 when compared with the
increasing number of cases in Sa˜o Miguel and Terceira islands
(the Azores), where more fatal cases have occurred in recent
years.14,15 In fact, leptospirosis is still not always notified16
nor even diagnosed, due to both its marked clinical poly-
morphism and to the difficulties involved in standard bacter-
iological and/or serological diagnoses.
The purpose of this retrospective seroepidemiologic
community-based study in the central and southern main-
land regions, and the Sa˜o Miguel, Terceira and Madeira
islands, was to summarize incidence, clinical symptoms,
prevalent serovars, and occupational risk of infection in
laboratory-confirmed human leptospirosis cases in Portugal.
Data were collected during eighteen years at the Unit of
Leptospirosis and Lyme Borreliosis (ULBL) at the Institute of
Hygiene and Tropical Medicine (IHMT) of the New University
of Lisbon, one of the two governmental institutions where
diagnostic testing for leptospirosis takes place.Table 1 Regional distribution of 1024 cases of leptospirosis in Po
Populationa No. te
Central mainland (1986—2003) 1 944 353 2629
Southern mainland (1986—2003) 3 704 668 1348
Azores islands (Sa˜o Miguel and Terceira)
(1992—2003)
182 900 594
Madeira islands (2001—2003) 245 011 47
Total (%) 4618
a Average of Territorial censuses of estimated resident population fro
(Instituto Nacional de Estatı´stica — INE).Patients and methods
Study areas
In addition to the central and southern regions of mainland
Portugal, with populations of 1 944 000 and 3 705 000,
respectively (average of the censuses of estimated resident
population for 1981, 1991 and 2001),17 the Azorean islands of
Sa˜o Miguel and Terceira were also included in the study
(Table 1). These two islands belong to the Archipelago of
the Azores, which is composed of seven volcanic islands,
administrated autonomously, and situated in the middle of
the North Atlantic Ocean approximately 1500 km from the
European coast and 3900 km from the North American coast.
Nowadays, over 237 000 people live on these islands,18 which
cover a total area of 2322 km2. About 77% of the inhabitants
live on the islands of Sa˜o Miguel (128 000) and Terceira
(55 000).19
In addition, the island of Madeira, with a total area of
741 km2 and a population of 245 000,19 was analyzed from
2001.
The basic demographic and environmental features of
these islands have been described previously.20,21 Azores
residents are predominantly rural workers who earn money
through cattle-associated activities, whereas in Madeira, the
major economic activity is tourism.
Hospital patients
Between January 1986 and December 2003, a total of 6702
serum samples from 4618 patients presenting to hospitals
with symptoms consistent with leptospirosis, from urban and
rural regions, were analyzed. Sixty five per cent were males
and the overall age range was 25—74 in 2027 (77%) out of the
2632 whose age was available.
An individual standardized questionnaire was used,
including identification, onset of symptoms, clinical, and
occupational and social exposure. Until 1992, the patient
reports came only from mainland hospitals — central (57%)
and southern (29%) — because those from the islands were
only submitted to the IHMT from 1992 for Sa˜o Miguel, 1993
for Terceira, and 2001 for Madeira. Considering the need
to obtain more epidemiological data (namely onset of
symptoms and age) and more than one serum sample per
patient, complementary information was always requestedrtugal (1986—2003)
sted No. cases (%) Mean annual incidence (/100 000)
Annual mean SD Range
604 (23.0) 1.7 0.62 0.7—2.6
163 (12.1) 0.3 0.13 0.0—0.5
244 (41.1) 11.1 6.34 2.7—23.5
13 (27.7) 1.8 1.34 0.8—3.3
1024 (22.2)
m 1981, 1991 and/or 2001 according to the study period per region
380 M.L. Vieira et al.from the Health Services, especially for the leptospirosis-
confirmed cases with a serological follow-up. Nevertheless,
this laboratory information is absent for a significant number
of mainland and Azores confirmed cases, and more recently
for Madeira seropositives. For this reason, these incomplete
individual questionnaires were only considered for regional
incidence rates and gender distribution analyses. This latest
group includes all the Madeira patients, for whom there are
no data other than the patient’s name.
Laboratory tests
Sera were examined by the microagglutination test (MAT) for
the presence of antibodies against pathogenic Leptospira,
using the reference technique described previously.4,22
Briefly, 19 serogroups, represented by a battery of 26 refer-
ence serovars (including the five local circulating strains),
were used as live culture antigens. These were Australis
(Australis serogroup); Autumnalis (Autumnalis); Ballum,
Arborea and Castellonis (Ballum); Bataviae (Bataviae); Cani-
cola (Canicola); Celledoni (Celledoni); Cynopteri (Cynop-
teri); Grippotyphosa (Grippotyphosa); Hebdomadis
(Hebdomadis); Copenhageni and Icterohaemorrhagiae (Icter-
ohaemorrhagiae); Javanica (Javanica); Louisiana (Louisi-
ana); Mini (Mini); Panama (Panama); Mozdok and Pomona
(Pomona); Pyrogenes (Pyrogenes); Hardjo, Saxkoebing, Sej-
roe and Wolffi (Sejroe); and Tarassovi (Tarassovi). The sapro-
phytic serovar Patoc (serogroup Semaranga) was used as an
internal control. Samples were screened at 1:40 dilution and
reacting sera were further double-titrated to the end point,
defined as the highest dilution that agglutinated 50% or more
of the leptospires.
Sera were frozen immediately (20 8C) for further pro-
cessing if serological examination did not take place within a
few days of arrival at the laboratory. Sera were retested
whenever anomalous results were observed. In a very few
cases clinical specimens were cultured in EMJH semi-solid
medium for primary isolation as described previously.23,24
Leptospirosis case definition and diagnostic
criteria
A laboratory-confirmed case of leptospirosis in this long-
term series was defined as a hospitalized patient meeting
clinically compatible symptoms (fever, myalgia, headache,
nausea/vomiting, prostration and/or jaundice), with labo-
ratory criteria for confirmation: (i) significant MAT titers
(1:160) in one or more serum specimens; (ii) four-fold or
greater increase in MAT titer(s); (iii) seronegative conver-
sion to a minimum agglutination titer of 160; or (iv) isolation
of Leptospira. The use of this cut-off for positivity (instead
of the well known 1:100 in non-endemic areas)4 resulted
from our epidemiological situation, which is characterized
by some hospitalized confirmed cases with low antibody
titers, even in areas of moderate endemicity like the
Azores. A laboratory-confirmed probable case was defined
as having a MAT titer of 80 in a single serum sample from a
symptomatic patient.
To designate the presumptive serogroup of the infecting
serovar, unique titers of 160 or higher were always considered
as significant in both the single serum samples or in the latestpatient sample in the convalescent phase. When the highest
titer was the same with two or more serogroups, the final
result was considered as ‘serogroup not determined’.
Data analysis
Data for the last eight years were analysed using SPSS soft-
ware for Windows (version 11.5). In some cases, this eight-
year period was compared to the previous ten-year period
with the assumption that the lack of two years does not
influence the comparison.
Geometric mean titers (GMT) of MAT results were calcu-
lated according to Sokal and Rohlf.25 Statistical analysis was
performed with the Pearson Chi-square test, with a CI of 95%,
using the same SPSS software.
Results
Regional and annual distribution
During the 18-year study period, a total of 1024 (22%) symp-
tomatic patients were confirmed to have a current Leptos-
pira infection. The mean annual incidence rate in the Azores
islands was much higher (11.1 per 100 000 population)
when compared to the other regions (Table 1). As regards
the annual distribution of leptospirosis confirmed cases
(Table 2), an average of 57 cases per year (range 16 to
93 cases, SD 23.85) was observed overall. Although the
total number of cases for the Azores was smaller than that
for the mainland (Table 2), the annual mean frequency of
20 cases was significantly ( p < 0.001) greater than the
equivalent number of 45 cases for the mainland in the same
twelve-year period.
Regarding the overall seropositivity rates, a significantly
higher percentage (27%; 609/2273) was observed in the most
recent eight-year period when compared to the percentage
previously obtained (18%; 415/2345) between 1986 and 1995
( p < 0.001). This finding appears to be the result of the
increased laboratory diagnosis of leptospirosis cases in cer-
tain regions, with significantly higher seropositivity rates
compared to previous years, namely, in the central mainland,
with 30% (324/1072 patients) and 18% (280/1557) seroposi-
tives, between 1996—2003 and 1986—1995, respectively
( p < 0.001), and in the Azores islands with 44% (126/286),
45% (82/182) and 29% (36/126) seropositives between 2000—
2003, 1996—1999 and 1992—1995, respectively ( p = 0.006).
During the eight-year study period 1996—2003, 2273
patients were examined with a total of 3324 serum samples.
These numbers were close to the 2345 patients and 3378 sera
observed for the previous ten-year period 1986—1995. In
addition, a more detailed analysis of the individual number
of serum samples in these two periods showed a clear reduc-
tion of sera examined per patient in recent years. Sixty five
per cent of the patients (1468 out of 2273) had only single
samples when compared to only 10% (235 out of 2345) with
unique serum samples previously. Except for those 17 lep-
tospirosis cases where a long-term follow-up of the humoral
immune response was undertaken between 1996 and 2003,
with an average of six serum samples per case during three to
four years, the remaining patients observed during this
period yielded two (27%; 620 patients), three (6%; 143)
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Table 2 Annual distribution by gender of leptospirosis cases in mainland Portugal, the Azores (Sa˜o Miguel and Terceira) and the Madeira islands
Year Total
tested
(no.)
Total
cases
(no.)
Mainland (center + south) The Azores (Sa˜o Miguel and Terceira) The Madeira islands
Males Females Males Females Males Females
Tested
(no.)
Cases
(no.)
% Tested
(no.)
Cases
(no.)
% Tested
(no.)
Cases
(no.)
% Tested
(no.)
Cases
(no.)
% Tested
(no.)
Cases
(no.)
% Tested
(no.)
Cases
(no.)
%
1986 162 16 89 9 10.1 73 7 9.6
1987 154 42 84 27 32.1 70 15 21.4
1988 246 64 134 39 29.1 112 25 22.3
1989 289 53 187 31 16.6 102 22 21.6
1990 271 27 193 15 7.8 78 12 15.4
1991 248 23 181 10 5.5 67 13 19.4
1992 267 46 131 21 16.0 124 19 15.3 12 6 50.0
1993 288 57 147 33 22.4 109 19 17.4 29 5 17.2 3 0 0.0
1994 232 40 114 16 14.0 74 16 21.6 37 7 18.9 7 1 14.3
1995 188 47 102 20 19.6 48 10 20.8 33 17 51.5 5 0 0.0
1996 229 65 122 25 20.5 70 16 22.9 33 24 72.7 4 0 0.0
1997 250 84 134 33 24.6 67 24 35.8 43 25 58.1 6 2 33.3
1998 274 81 135 33 24.4 82 29 35.4 48 16 33.3 9 3 33.3
1999 223 37 118 10 8.5 66 15 22.7 36 12 33.3 3 0 0.0
2000 260 85 127 34 26.8 84 27 32.1 41 22 53.7 8 2 25.0
2001 326 78 138 24 17.4 86 16 18.6 64 27 42.2 12 4 33.3 19 6 31.6 7 1 14.3
2002 397 86 189 38 20.1 121 17 14.0 69 27 39.1 8 1 12.5 6 3 50.0 4 0 0.0
2003 314 93 135 25 18.5 84 22 26.2 76 43 56.6 8 0 0.0 9 3 33.3 2 0 0.0
Total 4618 1024 2460 443 18.0 1517 324 21.4 521 231 44.3 73 13 17.8 34 12 35.3 13 1 7.7
382 M.L. Vieira et al.
Table 3 Age distribution of 672 (87.6%) out of 767 confirmed leptospirosis cases in mainland Portugal and the Azores (1992—2003)
Age group Populationa Mainland (center + south) Age group Populationa The Azores (Sa˜o Miguel
and Terceira)
Cases (no.) Cases/100 000 Cases (no.) Cases/100 000
1—14 352 388 6 0.1 1—14 41 603 1 1.3
15—24 322 118 16 0.4 15—24 32 780 36 9.2
25—34 328 648 44 1.1 25—49 65 936 133 16.7
35—44 327 952 63 1.6 50—64 23 243 40 14.2
45—54 292 573 91 2.6 65 20 615 19 7.7
55—64 268 040 100 3.1
65—74 259 147 96 3.1
75 197 531 27 1.1
Total 443 229
a Territorial census of 2001 with available data for age range.and four (1%; 25) serum samples per patient. In the first
ten years, the majority of the patients provided two (54%;
1266 patients) and three (27%; 633) sera per patient.
Regarding the average number of days to the first blood
sample in the 1468 (65%) out of 2273 patients between 1996
and 2003, a similar annual distribution was observed, with
an overall mean of 7.4 days (range 1—15, SD = 4.23) for
mainland and 7.2 days (range 2—15, SD = 3.20) for the two
Azores islands.
Case distribution
Six hundred and eighty six (67%) of 1024 leptospirosis
cases, including 12 of 13 seropositives from Madeira, were
males (Table 2), with a clear predominance in the AzoresTable 4 Annual distribution of mandatory notifications and numbe
Year Notifications a Deat
Males Females Total Male
1986 n.a. 4
1987 n.a. 1
1988 n.a. 7
1989 n.a. 2
1990 n.a. n.a. 25 12
1991 18 8 26 n.a.
1992 12 8 20 n.a.
1993 23 15 38 n.a.
1994 25 13 38 n.a.
1995 31 6 37 5
1996 32 7 39 15
1997 53 14 67 15
1998 71 21 92 15
1999 31 20 51 6
2000 25 20 45 7
2001 62 18 80 14
2002 27 10 37 7
2003 58 14 72
Total 468 174 667 110
n.a.: not available.
a Data from Direcc¸a˜o Geral Sau´de (DGS) between 1991 and 2002.
b Data from Instituto Nacional de Estatı´stica (INE) and Direcc¸a˜o Gera( p < 0.001) compared with the central and southern main-
land ( p = 0.01).
According to the available data for the past twelve years,
age was known in 672 (88%) of 767 laboratory-confirmed
cases (443 from mainland and 229 from the Azores) with
the following distribution: 1% under 14 years of age, 8%
were in the 15—24 age group, 70% in the 25—64 age group,
and 21% in the 65 and over age group (Table 3). In mainland
Portugal, the highest incidences of the disease were
observed between the ages of 25 and 75 years (range
1.1—3.1/100 000 population) whereas in the Azores
(Table 3), younger people (from 15 years) were more
affected (range 7.7—16.7/100 000), with a significantly
higher seropositivity rate compared to the mainland cases
for the same age group (15—24 years; p < 0.001).r of deaths between 1986 and 2003 in Portugal for leptospirosis
hsb Deaths/notifications
s Females Total Ratio
1 5 n.a.
0 1 n.a.
3 10 n.a.
1 3 n.a.
0 12 48.0
n.a. 7 26.9
n.a. 12 60.0
n.a. 14 36.8
n.a. 3 7.9
4 9 24.3
4 19 48.7
4 19 28.4
4 19 20.7
7 13 25.5
2 9 20.0
4 18 22.5
3 10 27.0
n.a. n.a.
37 183 27.4
l Sau´de (DGS) between 1986 and 2002.
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Figure 1 Distribution and seropositivity according to month of leptospirosis onset in 660 (88%) out of 751 MAT-confirmed cases
(1992—2003).
Figure 2 Clinical criteria on admission in 2855 (62%) out of
4618 examined patients (1986—2003).Considering the influence of both age and sex on the case
distribution, older women and men (65 years), with or
without rural activity, had similar infection risk ( p = 0.74).
Males from the Azores were more affected than females for
the remaining age groups.
Leptospirosis was the reported cause of death in 183
patients and of mandatory notification in 667 patients
(Table 4). All patients were hospitalized, but died despite
medical support. From the available data, between 1996 and
2002, the highest case-fatality rate for leptospirosis was
observed in the 60—69, 40—49 and 70—79 age groups, with
35, 18 and 17 cases, respectively, out of 107 death notifica-
tions.26 Overall, the fatality rate was higher among males
(75%). The reported notifications of disease, between 1991
and 2003 (Table 4), followed the same pattern as fatal cases
regarding gender (males 73%), and age, with the highest
disease frequency (112 out of 521 cases) in the 60—69 age
group. Of the remainder, most of the reported cases were
in the 50—59, 40—49 and 70—79 age groups with 90, 89 and
80 cases, respectively.26
Occupation and risk factors
Information concerning at least one of the following
data (county, profession or contact with animals) allowed
for an exposure classification in 880 (86%) out of the 1024
confirmed cases. The distribution of seroprevalence during
the eighteen-year period was affected by the rural origin
of the majority of the leptospirosis cases (695 out of 880,
79%), and thus with a significant link to professional activ-
ities, and/or contact with rodents and domestic animals.
The likely source of infection was investigated for 596 (58%)
of the leptospirosis cases with this type of information.
A significant association ( p < 0.001) was found with each
of the following risk sources for leptospirosis: untreated
water, cattle, pigs, dogs and rodents. Recreational risk
factors were not investigated because only four positive
cases reported leisure activities associated with bathing
in the central region of the country.Seasonal occurrence
Distribution according to month of leptospirosis onset in
660 (88%) out of 751 MAT-confirmed cases (1992—2003) is
shown in Figure 1. A winter distribution is evident, with the
peak months being October and December, besides the
months of August and September, with a significant per-
centage of cases in the summer time. The month of expo-
sure was taken as the month of onset of illness, except
when the onset date was between the 1st and 7th days.
In these cases exposure was assumed to have occurred
in the preceding month. Monthly case numbers varied from
27 cases in July to 88 in January. The average for the wetter
months (October—April) was 63 cases and for the drier
months (May—September) 43 cases.
Clinical presentation
From the clinical data available for 2855 (62%) of 4618
examined patients, numerous combinations of signs and
symptoms were reported on admission (Figure 2). The most
common presentation involved nonspecific clinical manifes-
tations, including fever (58%; 2678 patients), myalgia (21%;
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Table 5 Presumptive serogroup distribution of the 1024 out of 4618 leptospirosis cases by study period
Leptospira interrogans serogroup 1986—1995 1996 1997 1998 1999 2000 2001 2002 2003 Total %
Icterohaemorrhagiae 88 14 19 11 6 10 9 11 9 177 17.3
Pomona 91 6 11 9 2 4 2 2 5 132 12.9
Ballum 43 10 21 9 2 6 3 4 18 116 11.3
Sejroe 33 7 6 9 3 3 3 3 0 67 6.5
Australis 44 1 2 1 0 2 1 1 1 53 5.2
Grippotyphosa 27 0 2 3 0 2 0 1 0 35 3.4
Canicola 10 6 0 0 0 0 0 0 0 16 1.6
Panama 12 0 0 0 0 0 0 1 0 13 1.3
Louisiana 0 0 0 2 0 0 0 0 0 2 0.2
Others a 9 5 4 0 4 3 2 2 5 34 3.3
Cross-agglutination 58 16 19 37 20 55 58 61 55 379 37.0
Total 415 65 84 81 37 85 78 86 93 1024
a Tarassovi (9), Autumnalis (6), Hebdomadis (6), Mini (5), Pyrogenes (4), and Bataviae, Cynopteri, Javanica and Panama (1 each).969) and headache (18%; 854). Twelve per cent had jaundice
(535 patients) and 2% (61) of these hadmeningism. Aminority
of patients (0.7%; 31) had other features, namely, conjunc-
tival suffusion, exanthema and vasculitis.
In the patients testing negative (1467 out of 2855), the
main clinical diagnosis was flu-like illness (55%). As regards
the clinical diagnosis of the 1024 MAT-confirmed leptospiro-
sis cases, seven main categories were observed. Anicteric
and icteric leptospirosis accounted for the majority (49%)
of the cases (330 and 115, respectively), followed by pyrexia
of unknown origin (22%; 197 cases), hepatitis (8%; 68),
acute kidney failure and meningitis (6% each; 56 and 53),
and pneumonia (5%; 43).
Laboratory confirmation
Between 1996 and 2003, 517 (85%) of 609 patients were
diagnosed serologically by the detection of a significant
titer (1:160) at the first serum sample, with a geometric
mean titer (GMT) of 801 ranging from 1125 in 1996 to 427
in 2002. Of the remaining 92 cases, 12% seroconverted
from negative and 88% showed a four-fold increase or
greater in MAT doubtful or positive titers in paired serum
samples, with a mean GMT of 804. From the 241 (47%) of
the 517 cases with a positive MAT titer in the first serum
sample, 88.4% had unique titers of 1:320 or greater.
There was presumptive serologic evidence of nine major
infecting serogroups with Icterohaemorrhagiae the largest
serogroup followed by Pomona and Ballum (Table 5). Cross-
agglutination with at least two serogroups occurred in 403
caseswith sera showing co-agglutinins in single or paired acute
stage samples at significant titers, in particular, inmore recent
years. Cross-agglutination was found particularly between
Icterohaemorrhagiae and Ballum (18%), Icterohaemorrhagiae
and Sejroe (17%), or Pomona and Sejroe (16%).
Discussion
Leptospirosis has been confirmed as a steadily increasing
public health problem in Portugal, particularly in the
central mainland and Sa˜o Miguel and Terceira islands, over
periods of eighteen and twelve years, respectively. Thepresent series of 1024 cases is unique in presenting regional
information on leptospirosis in two of the most affected
areas.
There has been a significant increase in case-frequency
reporting since 1997, due to the compulsory notification
system of Direcc¸a˜o Geral de Sau´de (General Directorate of
Health)13, with the highest numbers in 1998 and 2001 (92 and
80 cases, respectively). Moreover, between 1996 and 2003,
only 135 cases are known to have been officially reported in
other regions (including 45 in the north of Portugal) when
compared to the 134 and 211 notified cases, respectively, for
the Azores and the central mainland region in the same
period (Figure 3).26
The semi-tropical Azores islands, with a mean annual inci-
dence (1992—2003) of 11.1 cases per 100 000 population, had
the same high risk of exposure as some tropical countries such
as Tahiti (11.3), the French West Indies (8.9) and La Re´union
Mayotte (7.4).27 Furthermore, the mean annual incidence
(1986—2003) of 1.7 cases per 100 000 in mainland Portugal
was much higher than the reported incidence of 0.4 cases per
100 000 in France, assumed to be one of the highest inWestern
Europe.28 These data likely reflect a true increase in cases
mainly due to global climate changes and the consequent
increasing contact with contaminated water and rats.
A seasonal winter distribution was evident, as reported
elsewhere.1,2,29 In fact, climatic conditions in our country are
favorable for Leptospira transmission, particularly on the
Azores islands,30,31 where the level of humidity is high
(77% average/year), and precipitation, although regular
and well distributed throughout the year, has a greater
abundance during the winter months.21 The observed global
higher incidence rates in wetter years, namely 1988/1989
and 1997/1998,13,26 demonstrated the recognized impor-
tance of variation in rainfall in human transmission.29 More-
over, the well-known warming effects of the Gulf Stream in
recent years with a mean air temperature around 13 8C
during the colder months (January/February), and a mean
value of 23 8C in the warmer months (July/August), may also
have contributed to the greater survival time of viable
leptospires in surface waters.
Besides vaccination of domestic animals and rodent con-
trol, the prevention of occupational human exposure is
recognized as a basic control measure. In this case, the
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Figure 3 Distribution of 642 mandatory notifications from Direcc¸a˜o Geral de Sau´de (DGS), and 822 laboratory-confirmed cases of
leptospirosis at the Institute of Hygiene and Tropical Medicine (IHMT).use of protective clothing, avoiding fresh water ponds, wash-
ing hands after a risk contact with contaminated material,
and early reporting of symptoms and signs compatible with a
differential diagnosis of leptospirosis, should be widely
implemented in the risk-areas.
The disease predominantly affects active adult men,
following the universal trend in temperate zones,7,8 through-
out the different age groups (15 to 75 years). Older women
(65 years) were equally at risk in both regions. This finding
reflects a changing social pattern over recent years, in which
retired women are more likely to undertake manual work in
higher risk environments.
Leptospirosis in males, being more significant in Sa˜o
Miguel and Terceira, can be explained by a number of
potential risk factors, besides the strong environmental
risk exposure with highly infected small mammals (Mus
musculus, Rattus rattus/R. norvegicus and Erinaceus euro-
paeus), which showed an overall Leptospira isolation rate
of 53% in Sa˜o Miguel and 46% in Terceira, over a three-year
period.30 In addition, a significantly high transmission risk
from house mice in Terceira was also reported,31 emphasiz-
ing the need to develop integrated control programs
to reduce the risk of human disease. Such an approach
has just been implemented.
The clinical picture of leptospirosis ranges from influ-
enza-like to fulminant disease. Being highly variable and
dependent on the infecting serovar, infection dose, host
factors or a combination of these,4 laboratory confirmation
is important for accurate diagnosis. Fatal cases in young
people progress rapidly in the first week of the disease to
acute renal failure and respiratory distress syndrome,
before seroconversion occurs.
According to official data, between 1986 and 2002,
fewer than 19 deaths due to leptospirosis have been
reported each year.14 It is important to note that there
has been increasing attention given to this zoonosis, which
has resulted in an earlier recognition and presumptive
clinical diagnosis, with earlier initiation of appropriate
therapy, including placement in intensive care units. How-
ever, we assume that a great number of undiagnosed cases
occurred in earlier times, before the recent increased
awareness of leptospirosis as an important public health
problem.32Although isolation was not usually attempted for logistic
reasons, the standard MAT was always performed. Leptos-
pires of nine serogroups were responsible for most of the
cases, but Icterohaemorrhagiae and Ballum were respec-
tively the first and the third major infecting serogroups.
These MAT results are in agreement with the previously
confirmed circulating serovars Copenhageni/Icterohaemor-
rhagiae and Arborea/Ballum in the endemic areas, by kidney
isolation from rodents (genera Mus and Rattus) and/or
insectivores (Erinaceus europaeus).33 As regards Pomona,
the second major serogroup only identified in patients from
mainland Portugal, its predominance correlates well with
the field isolates of serovar Mozdok, not only in pigs34 but
also in different sylvatic species, namely the insectivore
Crocidura russula, the field-mouse Mus spretus and the two
rats Rattus rattus and R. norvegicus.33 Another strain of
serogroup Pomona, typed as L. kirschneri serovar Tsarat-
sovo, was also recently obtained from an abattoir horse.35
Of the remaining serogroups, strains belonging to Sejroe
(serovar Hardjo), Australis (serovar Bratislava) and Canicola
(serovar Canicola) groups have all been recovered from
domestic animals in Portugal as follows: from cattle,36 from
pigs and horses34,35 and from dogs (Collares-Pereira, unpub-
lished data), respectively.
Leptospiral MAT conducted on a large number (n = 241;
40%) of unique serum samples of confirmed cases between
1996 and 2003, yielded agglutination titres 320 (data not
shown). Prior to 1996 the titres were much higher
( p = 0.001). This difference may be attributed to earlier
therapy due to the recognition of disease and support from
the clinical laboratory, since there has been no change in the
form of therapy.1,4
Infection with serovars from the Icterohaemorrhagiae
serogroup has been reported to be associated with increased
disease severity,7,9 while a number of published studies
have questioned the relationship between infecting ser-
ogroups and severity.36—39 In the current study, severe cases
of leptospirosis were associated with the three major infect-
ing serogroups but Icterohaemorrhagiae was confirmed to
have a clear association with the more serious forms, parti-
cularly in Terceira and Sa˜o Miguel.32
In conclusion, the knowledge that demographic, climatic,
and environmental changes can place new areas or specific
386 M.L. Vieira et al.populations at increased risk for infection indicates the need
for good surveillance, communication, and laboratory sup-
port to reduce the impact of leptospirosis in Portugal.
Acknowledgments
We are grateful to Luzia Gonc¸alves for statistical support and
review of the data, Fa´tima Figueiredo for epidemiological
support, and Ben Adler for comments and reviewing the
manuscript. Thanks are also especially due to the practi-
tioners and clinical pathologists of the Hospitais da Universi-
dade de Coimbra (in the mainland), and of the Hospital de
Ponta Delgada in Sa˜o Miguel and Hospital de Angra do Her-
oı´smo in Terceira for all the precious collaboration on the
follow-up of the examined patients.
Conflict of interest: No conflict of interest to declare.
References
1. Levett P. Leptospirosis. Clin Microbiol Rev 2001;14:296—326.
2. Meites E, Jay MT, Deresinski S, Shieh WJ, Zaki SR, Tompkins L,
et al. Reemerging leptospirosis, California. Emerg Infect Dis
2004;10:406—12.
3. Chaudhry R, Premlatha MM, Mohanty S, Dhawan B, Singh KK, Dey
AB. Emerging leptospirosis, North India. Emerg Infect Dis
2002;8:1526—7.
4. Faine S, Adler B, Bolin C, Perolat P. Leptospira and leptospirosis.
2nd ed. Melbourne/Vic. Australia: MediSci; 1999.
5. Johnson MAS, Smith H, Joseph P, Gilman RH, Bautista CT, Campo
KJ, et al. Environmental exposure and leptospirosis, Peru. Emerg
Infect Dis 2004;10:1016—22.
6. Sejvar J, Bancroft E, Winthrop K, Bettinger J, Bajani M, Bragg S,
et al. Leptospirosis in ‘Eco-Challenge’ athletes, Malaysian Bor-
neo, 2000. Emerg Infect Dis 2003;9:702—7.
7. Christova I, Tasseva E, Manev H. Human leptospirosis in Bul-
garia, 1989—2001: epidemiological, clinical, and serological
features (Short communication). Scand J Infect Dis 2003;35:
869—72.
8. Ciceroni L, Stepan E, Pinto A, Pizzocaro P, Dettori G, Franzin L,
et al. Epidemiological trend of human leptospirosis in Italy
between 1994 and 1996. Eur J Epidemiol 2000;16:79—86.
9. Romero EC, Bernardo CCM. Yasuda PH. Human leptospirosis: a
twenty-nine-year serological study in Sa˜o Paulo, Brazil. Rev Inst
Med Trop S Paulo 2003;45:245—8.
10. Sambasiva RR, Naveen G, Bhalla P, Agarwal SK. Leptospirosis
in India and the rest of the World. Br J Infect Dis 2003;7:
178—93.
11. Figueira L. Espiroquetose ictero-hemorra´gica em Lisboa. Lisboa
Me´dica 1931;8:855—6.
12. Collares-Pereira M. Epidemiology of leptospirosis in Portugal.
Trans R Soc Trop Med Hyg 1989;83:132.
13. Portugal — Direcc¸a˜o Geral de Sau´de. Leptospirose em Portugal.
In: Obsv Nac Sau´de — http://www.onsa.pt accessed 15-12-1999.
14. Portugal — Instituto Nacional de Estatı´stica. In: Estatı´sticas da
Sau´de 1995—2003, Morbilidade e Mortalidade geral. Available at:
http://www.ine.pt.
15. Collares-Pereira M, Vieira ML. Fatal leptospirosis, Azores islands.
Report submitted by Institute of Hygiene and Tropical Medicine,
Lisbon, Portugal. Wkly Epidemiol Rec 2001;15:109—11.
16. Falca˜o JM, Nogueira PJ, Matias Dias C, Pimenta ZP. Leptospirosis
in Portugal: epidemiology from 1991 to 1997. Eurosurv Month
Arch 1999;4:44—7.
17. Portugal — Instituto Nacional de Estatı´stica. Censos 1960. 70, 81,
91 — Anua´rio Estatı´stico 1996. and Censos 1991. 2001 INE (ed),
Lisboa, 2004. Available at: http://www.ine.pt.18. Portugal — Instituto Nacional de Estatı´stica. In: Base Geogra´fica
de Referenciac¸a˜o de Informac¸a˜o, Censos 2001; Parte I, Territo´rio
e Populac¸a˜o, Cap 1, Territo´rio e Demografia (Ac¸ores); 2002, p.
15—27.
19. Portugal — Instituto Geogra´fico e Cadastral. In: Situac¸a˜o Geo-
gra´fica dos Territo´rios Portugueses: Continente, Madeira e
Ac¸ores; 2001, p. 20.
20. Clima Madeira. Available at: http://www.madeira-web.com.
21. Portugal — Instituto de Meteorologia. In: Divisa˜o de Clima e
Alterac¸o˜es Clima´ticas, available at: http://www.meteo.pt
accessed 02-03-2004.
22. Dikken H, Kmety E. Serological typingmethods of leptospires. In:
Bergman T, Norris JR, editors.Methods in microbiology. London:
Academic Press; 1978. p. 259—308.
23. Ellinghausen HC, McCullough WG. Nutrition of Leptospira
Pomona and growth of 13 other serotypes: fractionation of oleic
albumin complex and medium bovine albumin and polysorbate
80. Am J Vet Res 1965;26:45—51.
24. Johnson RC, Harris VG. Differentiation of pathogenic and sapro-
phytic leptospires. I. Growth at low temperatures. J Bacteriol
1967;94:27—31.
25. Sokal RR, Rohlf F. Biometry: the principles and practice of
statistics in biological research. San Francisco: WH Freeman
and Company; 1969.
26. Portugal — Direcc¸a˜o de Servic¸os de Informac¸a˜o e Ana´lise, Divisa˜o
de Epidemiologia. Doenc¸as de Declarac¸a˜o Obrigato´ria 1996—
2000 and 1999—2003. In: Estatı´sticas, Direcc¸a˜o-Geral de Sau´de
(ed), Lisboa; 2001, p. 49, and 2004, p. 12.
27. Baranton G, Postic D. Rapport Annuels d’Activite´ 2000, Centre
National de Re´fe´rence des Leptospiroses, Institut Pasteur,
France.
28. Perra A, Servas V, Terrier G, Postic G, Baranton G, Andre´-Fon-
taine G, et al. Clustered cases of leptospirosis in Rochefort,
France, June 2001. Eurosurv 2002;7:131—6.
29. Everard COR, Edwards CN, Everard JD, Carrington DG. A twelve-
year study of leptospirosis on Barbados. Eur J Epidemiol
1995;11:311—20.
30. Collares-Pereira M, Korver H, Terpstra WJ, Santos-Reis M, Ramal-
hinho MG, Mathias ML, et al. First epidemiological data on
pathogenic leptospires isolated on the Azorean islands. Eur J
Epidemiol 1997;13:435—41.
31. Collares-Pereira M, Mathias ML, Santos-Reis M, Ramalhinho MG,
Duarte-Rodrigues P. Rodents and Leptospira transmission risk in
Terceira island (Azores). Eur J Epidemiol 2000;16:1151—7.
32. Pacheco M, Paiva C, Collares-Pereira M, Vieira ML, Melo FM.
Contribuic¸a˜o para o estudo integrado da Leptospirose humana e
animal na Ilha de S. Miguel. Rev Port Doenc¸as Infecciosas
2000;23:77—84.
33. Collares-Pereira M, Korver H, Cao Thi BV, Santos-Reis M, Bellen-
ger E, Baranton G, et al. Analysis of Leptospira isolates from
mainland Portugal and the Azores islands. FEMS Microbiol Let-
ters 2000;185:181—7.
34. Rocha T. Isolation of Leptospira interrogans serovarmozdok from
aborted swine foetuses in Portugal. Vet Rec 1990;126:602.
35. Rocha T, Ellis WA, Montgomery J, Gilmore C, Regalla J, Brem S.
Microbiological and serological study of leptospirosis in horses at
slaughter: first isolations. Res Vet Sci 2004;76:199—202.
36. Collares-Pereira M. Bovine leptospirosis in cattle in Portugal:
bacteriological and serological findings. Vet Rec 1991;128:549—
50.
37. Yersin C, Bovet P, Me´rien F, Wong T, Panowsky J, Perolat P. Human
leptospirosis in the Seychelles (Indian Ocean): a population-
based study. Am J Trop Med Hyg 1998;59:933—40.
38. Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jar-
rige B, Daijardin JB. Leptospirosis: prognostic factors associated
with mortality. Clin Infect Dis 1997;25:720—4.
39. Perrocheau A, Perolat P. Epidemiology of leptospirosis in New
Caledonia (South Pacific). Eur J Epidemiol 1997;13:161—7.
